We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Sweetheart-Register: Risk Management of Diabetics With Acute Myocardial Infarction (Sweetheart)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01197742
First Posted: September 9, 2010
Last Update Posted: September 9, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Sanofi-Aventis Deutschland GmbH
Information provided by:
Stiftung Institut fuer Herzinfarktforschung
  Purpose
The Sweetheart register (Risk management of Diabetics with acute myocardial infarction) documents both the prevalence of pathologic glucose metabolism in consecutive high-risk patients with STEMI and NSTEMI in daily hospital routine as well as the anti-diabetic acute and long-term therapy. Furthermore the register will provide data about the implementation of new guidelines for the interventional and adjuvant medical therapy of STEMI and NSTEMI.

Condition
Diabetes STEMI NSTEMI Myocardial Infarction

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Sweetheart: Risiko-Management Von Diabetikern Mit Akutem Myokardinfarkt

Resource links provided by NLM:


Further study details as provided by Stiftung Institut fuer Herzinfarktforschung:

Primary Outcome Measures:
  • Documentation of the characteristics consecutive patients with acute STEMI or NSTEMI in daily hospital routine in Germany [ Time Frame: 04/01/2007-09/30/2009 ]

Secondary Outcome Measures:
  • Documentation of the fraction of patients with (I) a previous know Diabetes Mellitus (DM) type I and II, (II) a newly diagnosed DM, (III) diagnosed with IFG or IGT for the first time [ Time Frame: 04/01/2007-09/30/2009 ]
  • Documentation of acute invasive and adjuvant medicamentous therapy of STEMI and NSREMI in hospital daily routine in Germany [ Time Frame: 04/01/2007-09/30/2009 ]
  • Documentation of diabetic therapy during the acute phase of a myocardial infarction [ Time Frame: 04/01/2007-09/30/2009 ]
  • Documentation of the hospital mortality, the serious but non-fatal complications (stroke, re-myocardial infarction) and other bleeding complications [ Time Frame: 04/01/2007-09/30/2009 ]
  • Verification of the implementation of a therapy according to the guidelines for STEMI / NSTEMI in daily hospital routine [ Time Frame: 04/01/2007-09/30/2009 ]

Enrollment: 2772
Study Start Date: October 2007
Study Completion Date: September 2009
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
all consecutive patients with acute (no older than 24 h) ST-Elevation Myocardial infarction or acute (no older than 24 h) Non-ST-Elevation Myocardial infarction.
Criteria

Inclusion Criteria:

  • consecutive patients with acute (no older than 24 h) ST-Elevation Myocardial infarction
  • consecutive patients with acute (no older than 24 h) Non-ST-Elevation Myocardial infarction

Exclusion Criteria:

  • missing informed consent
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01197742


Locations
Germany
Städ Krankenhaus münchen Schwabing
München, Germany, 80804
Klinikum Nürnberg Süd /Cardiology
Nürnberg, Germany, 90471
Sponsors and Collaborators
Stiftung Institut fuer Herzinfarktforschung
Sanofi-Aventis Deutschland GmbH
Investigators
Study Chair: Anselm K Gitt, MD Stiftung Institut für Herzinfarktforschung
Study Chair: Jochen Senges, MD Stiftung Institut für Herzinfarktforschung
  More Information

Responsible Party: Jochen Senges, MD, Stiftung Institut fuer Herzinfarktforschung (Foundation for Cardiac Infarction Research)
ClinicalTrials.gov Identifier: NCT01197742     History of Changes
Other Study ID Numbers: Sweetheart
First Submitted: September 7, 2010
First Posted: September 9, 2010
Last Update Posted: September 9, 2010
Last Verified: September 2010

Keywords provided by Stiftung Institut fuer Herzinfarktforschung:
Diabetes
STEMI
NSTEMI
Myocardial infarction

Additional relevant MeSH terms:
Infarction
Myocardial Infarction
Ischemia
Pathologic Processes
Necrosis
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases